A detailed history of Dunhill Financial, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Dunhill Financial, LLC holds 392 shares of ABT stock, worth $45,197. This represents 0.03% of its overall portfolio holdings.

Number of Shares
392
Previous 198 97.98%
Holding current value
$45,197
Previous $22.5 Million 80.85%
% of portfolio
0.03%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$100.73 - $112.44 $19,541 - $21,813
194 Added 97.98%
392 $40.8 Million
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $2,190 - $2,419
20 Added 11.24%
198 $22.5 Million
Q4 2023

Feb 12, 2024

BUY
$90.19 - $110.4 $16,053 - $19,651
178 New
178 $19.5 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Dunhill Financial, LLC Portfolio

Follow Dunhill Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dunhill Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dunhill Financial, LLC with notifications on news.